Retatrutide

For laboratory research use only. Not for human consumption.

Retatrutide is a synthetic peptide studied for its effects on metabolic regulation and body-weight physiology. It is designed to act as a multi-receptor agonist, engaging pathways involved in appetite signalling, energy balance, and glucose homeostasis. In research settings, retatrutide is commonly referenced for investigations into incretin/glucagon-related mechanisms, including impacts on satiety, insulin dynamics, and lipid metabolism, making it a useful tool compound for studying systemic metabolic pathways.

Retatrutide is under investigation in clinical trial NCT06354660 (Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)).

National Center for Biotechnology Information. “PubChem Compound Summary for CID 9831659, Ipamorelin” PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Ipamorelin.